News and Trends 23 Mar 2016
Leading German Biotech Spins Off a New Startup in Autoimmune Diseases
Evotec (Germany) has launched a spin-off, Topas Therapeutics, to create nanoparticle-based therapeutics to treat immunological disorders. After starting a collaboration for microbiome-related diseases and entering the immuno-oncology field, Evotec is creating a spin-off dedicated to autoimmune diseases. This new biotech, Topas Therapeutics, is based on a technology that induces liver tolerance to specific antigens. This platform could be used to create breakthrough therapies for […]